Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice
Authors:
- 1 July 2007
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 28 (7) , 945-952
Abstract
To determine whether the cysteinyl leukotriene receptor 1 (CysLT1 receptor) modulates brain cryoinjury and whether the CysLT1 receptor antagonist pranlukast exerts a time-dependent protective effect on cryoinjury in mice. Brain cryoinjury was induced by applying a liquid nitrogen-cooled metal probe to the surface of the skull for 30 s. Brain lesion, neuron density, and endogenous IgG exudation were observed 24 h after cryoinjury. Transcription and the expresion of the CysLT1 receptor were detected by RT-PCR and immunoblotting, and the localization of the receptor protein by double immunofluorescence. The mRNA and protein expressions of the CysLT1 receptor were upregulated in the brain 6-24 h after cryoinjury, and the CysLT1 receptor protein was primarily localized in the neurons, not in the neurons, not in the astrocytes or microglia. Pre-injury treatments with multi-doses and a single dose of pranlukast (0.1 mg/kg) attenuated cryoinjury, postinjury single dose (0.1 mg/kg) at 30 min (not 1 h) after cryoinjury was also effective. The CysLT1 receptor modulates cryoinjury in mice at least partly, and postinjury treatment with its antagonist pranlukast exerts the protective effect with a therapeutic window of 30 min.Keywords
This publication has 29 references indexed in Scilit:
- Cysteinyl leukotriene receptors CysLT1and CysLT2are upregulated in acute neuronal injury after focal cerebral ischemia in miceActa Pharmacologica Sinica, 2006
- Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in miceActa Pharmacologica Sinica, 2006
- Increased angiopoietin2 expression is associated with endothelial apoptosis and blood–brain barrier breakdownLaboratory Investigation, 2005
- The p53-independent nuclear translocation of Cyclin G1 in degenerating neurons by ischemic and traumatic insultsExperimental Neurology, 2005
- Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, Dose- and Time-Dependently Protects against Focal Cerebral Ischemia in MicePharmacology, 2004
- Clinical potential of minocycline for neurodegenerative disordersNeurobiology of Disease, 2004
- Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumorsNeuroscience Letters, 2004
- Cysteinyl‐leukotriene receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl leukotrienesThe FASEB Journal, 2004
- International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin ReceptorsPharmacological Reviews, 2003
- Regional Generation of Leukotriene C4 After Experimental Brain Injury in Anesthetized RatsJournal of Neurotrauma, 1996